Page 10: Research news on genetically engineered organisms

Genetically engineered organisms (GEOs) are biological entities—prokaryotic or eukaryotic—whose genomes have been deliberately modified using recombinant DNA technologies, genome editing tools (e.g., CRISPR-Cas systems, TALENs, ZFNs), or transgenic methods to introduce, delete, or alter specific genetic sequences. This topic encompasses the design, construction, and characterization of modified genomes; vector systems and delivery methods; control of gene expression; and assessment of phenotypic consequences, stability, and off-target effects. It also includes applications in basic research, biotechnology, agriculture, biopharmaceutical production, and synthetic biology, as well as associated biosafety, containment, and regulatory frameworks governing experimental and environmental use.

Novel biosensor detects genetically modified corn and soybean

The continually expanding toolkit from Mohit Verma's laboratory at Purdue University now includes a portable, paper-based biosensor for identifying genetically modified (GM) corn and soybean. The GM crop biosensor, based ...

Researchers advance technology for protecting engineered cells

Genetically engineered cell lines used in biomedical research have long been prone to misidentification and unauthorized use, wasting billions of dollars each year and jeopardizing critical scientific discoveries. These problems ...

Biologists engineer larger, tougher crops for fuel, bioproducts

Cell walls don't just provide support and protection for plants—they're also packed with energy-rich biomaterials that could open new pathways for additional fuel, chemical, and material sources in the U.S. That's why biologists ...

Gene-tweaked albino toads reveal hidden costs of losing pigment

Albino cane toads created using gene-editing technology reveal that albino animals face competitive disadvantages going far beyond their vulnerability to predators, according to new research published in Proceedings of the ...

Bioengineered bacteria could lead to therapeutic antibody drugs

A Cornell-led collaboration has devised a potentially low-cost method for producing antibodies for therapeutic treatments. They've bioengineered bacteria with an overlooked enzyme that can attach complex sugars, known as ...

page 10 from 16